- Home
- WTBA vs DCTH Comparison
WTBA vs DCTH Comparison
Compare WTBA & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WTBA | DCTH |
|---|---|---|
| Founded | 1893 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 342.0M | 350.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | WTBA | DCTH |
|---|---|---|
| Price | $23.13 | $10.06 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $23.50 | $22.60 |
| AVG Volume (30 Days) | 40.2K | ★ 682.8K |
| Earning Date | 01-29-2026 | 11-04-2025 |
| Dividend Yield | ★ 4.31% | N/A |
| EPS Growth | ★ 49.53 | N/A |
| EPS | ★ 1.90 | 0.03 |
| Revenue | ★ $91,783,000.00 | $79,603,000.00 |
| Revenue This Year | $25.05 | $131.97 |
| Revenue Next Year | $10.87 | $38.84 |
| P/E Ratio | ★ $12.21 | $291.54 |
| Revenue Growth | 19.66 | ★ 251.54 |
| 52 Week Low | $17.31 | $8.12 |
| 52 Week High | $24.27 | $18.23 |
Technical Indicators
Market Signals| Indicator | WTBA | DCTH |
|---|---|---|
| Relative Strength Index (RSI) | 57.37 | 55.89 |
| Support Level | $23.47 | $9.84 |
| Resistance Level | $24.27 | $10.28 |
| Average True Range (ATR) | 0.54 | 0.45 |
| MACD | 0.05 | 0.04 |
| Stochastic Oscillator | 48.65 | 57.50 |
Price Performance
Historical ComparisonAbout WTBA West Bancorporation
West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings and money market accounts and time certificates of deposit. West Bank also offers online banking, mobile banking, and treasury management services, which help to meet the banking needs of its customers. Treasury management services offered to business customers include cash management, client-generated automated clearing house transactions, remote deposit, and fraud protection services. Also offered are merchant credit card processing and corporate credit cards. The bank operates only in the United States of America region.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.